施惠华,刘旭

• 1:上海交通大学附属胸科医院心内科

摘要(Abstract)：

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 施惠华,刘旭

参考文献(References)：

• [1]Kannel WB,Abbott RD,Savage DD,et al.Epidemiologic fea-tures of chronic atrial fibrillation:The Framingham Study.NEngl J Med,1982,306:1018-1022.
• [2]Benjamin EJ,Wolf PA,D′Agostino RB,et al.Impact of atrialfibrillation on the risk of death:The Framingham Heart Study.Circulation,1998,98:946-952.
• [3]Bruins P,Velthuis H,Yazdanbakhsh AP,et al.Activation ofthe complement system during and after cardiopulmonary bypasssurgery:postsurgery activation involves C-reactive protein and isassociated with postoperative arrhythmia.Circulation,1997,96:3542-3548.
• [4]Chung MK,Martin DO,Sprecher D,et al.C-reactive protein el-evation in patients with atrial arrhythmias:inflammatory mecha-nisms and persistence of atrial fibrillation.Circulation,2001,104:2886-2891.
• [5]Aviles RJ,Martin DO,Apperson-Hansen C,et al.Inflammationas a risk factor for atrial fibrillation.Circulation,2003,108:3006-3010.
• [6]Sata N,Hamada N,Horinouchi T,et al.C-reactive protein andatrial fibrillation.Is inflammation a consequence or a cause of at-rial fibrillation?Jpn Heart J,2004,45:441-445.
• [7]Frustaci A,Chimenti C,Bellocci F,et al.Histological substrateof atrial biopsies in patients with lone atrial fibrillation.Circula-tion,1997,96:1180-1184.
• [8]Voros S,Yang Z,Bove CM,et al.Interaction between AT1 andAT2 receptors during postinfarction left ventricular remodeling.Am J Physiol Heart Circ Physiol,2006,290:H1004-H1010.
• [9]Nakashima H,Kumagai K,Urata H,et al.AngiotensinⅡan-tagonist prevents electrical remodeling inatrial fibrillation.Circu-lation,2000,101:2612-2617.
• [10]Brilla CG,Zhou G,Matsubara L,et al.Collagen metabolism incultured adult rat cardic fibroblast:response to angiotensinⅡand aldosterone.J Mol Cell Cardiol,1994,26:809-820.
• [11]Azar RR,Rinfret S,Theroux P,et al.A randomized placebo-controlled trial to assess the efficacy of antiinflammatory therapywith methylprednisolone in unstable angina(MUNA trial).EurHeart J,2000,21:2026-2032.
• [12]Siu CW,Lau CP,Tse HF.Prevention of atrial fibrillation recur-rence by statin therapy in patients with lone atrial fibrillation aftersuccessful cardioversion.Am J Cardiol,2003,92:1343-1345.
• [13]Patti G,Chello M,Candura D,et al.Randomized trial of atorv-astatin for reduction of postoperative atrial fibrillation in patientsundergoing cardiac surgery:results of the ARMYDA-3(Atorvas-tatin for reduction of myocardial dysrhythmia after cardiac surger-y)study.Circulation,2006,114:1455-1461.
• [14]Marin F,Pascual DA,Roldan V,et al.Statins and postoperativerisk of atrial fibrillation following coronary artery bypass grafting.Am J Cardiol,2006,97:55-60.
• [15]Kumagai K,Nakashima H,Saku K.The HMG-CoA reductaseinhibitor atorvastatin prevents atrial fibrillation by inhibiting in-flammation in a canine sterile pericarditis model.CardiovascRes,2004,62:105-111.
• [16]Tveit A,Grundtvig M,Gundersen T,et al.Analysis of pravasta-tin to prevent recurrence of atrial fibrillation after electrical card-ioversion.Am J Cardiol,2004,93:780-782.
• [17]Dernellis J,Panaretou M.Relationship between c-reactive pro-tein concentrations during glucocorticoid therapy and recurrent at-rial fibrillation.Eur Heart J,2004,25:1100-1107.
• [18]Korantzopoulos P,Kolettis TM,Kountouris E,et al.Oral vita-min C administration reduces early recurrence rates after electricalcardioversion of persistent atrial fibrillation and attenuates associ-ated inflammation.Int J Cardiol,2005,102:321-326.
• [19]Li D,Shinagawa K,Pang L,et al.Effects of angiotensin-conver-ting enzyme inhibition on the development of the atrial fibrillationsubstrate in dogs with ventricular tachypacing-induced congestiveheart failure.Circulation,2001,104:2608-2614.
• [20]Zaman AG,Kearney MT,Schecter C,et al.Angiotensin-conver-ting enzyme inhibitors as adjunctive therapy in patients with per-sistent atrial fibrillation.Am Heart J,2004,147:823-827.
• [21]殷跃辉,刘增长,杨小渝,等.小剂量胺碘酮与培哚普利联合治疗阵发性心房颤动的临床疗效.中国循环杂志,2004,19:19-21.
• [22]龚浩,欧阳安定,胡威.胺碘酮联合依那普利预防阵发性心房颤动复发的临床观察.中国循环杂志,2004,19:415.
• [23]吴书林,薛玉梅,钱卫民,等.心房颤动患者心房肌细胞离子重塑及缬沙坦的干预研究.中华心血管病杂志,2004,32:197-201.
• [24]陈东妹,王碧炯,王珊珊.ACEI合AngⅡ受体拮抗剂治疗心衰合并心房颤动.浙江中西医结合杂志,2006,16:19-20.